Information Provided By:
Fly News Breaks for February 24, 2020
Feb 24, 2020 | 07:14 EDT
H.C. Wainwright analyst Debjit Chattopadhyay raised the firm's price target on Galapagos to $302 from $205 and reiterates a Buy rating on the shares. The excluding filgotinib pipeline is expected to generate mature and proof of concept data over the next 12 months, Chattopadhyay tells investors in a research note.
News For GLPG From the Last 2 Days
There are no results for your query GLPG